City

Duarte (1)

Jacksonville (1)

Omaha (1)

Rochester (1)

Scottsdale (1)

Overall Status

Withdrawn (2)

Completed (1)

Phase

phase 1 (3)

Sponsor

City of Hope Medical Center (1)

Mayo Clinic (1)

University of Nebraska (1)

Collaborator

National Cancer Institute (NCI) (3)

Adherex Technologies, Inc. (1)

Intervention

laboratory biomarker analysis (3)

cisplatin (2)

gemcitabine hydrochloride (2)

adh-1 (1)

capecitabine (1)

pharmacological study (1)

radioembolization (1)

ricolinostat (1)

Study Documents

Intervention Type

drug (3)

other (3)

radiation (1)

Funder Type

Other (3)

Study Type

Interventional (3)

stage ivb intrahepatic cholangiocarcinoma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Ampulla of Vater Adenocarcinoma, Gallbladder Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Omaha (ADH-1,

Completed

Ampulla of Vater Adenocarcinoma
+19 more

ADH-1
+3 more

Omaha, Nebraska

University of Nebraska Medical Center

Jan 26, 2018

Non-Resectable Cholangiocarcinoma, Recurrent Cholangiocarcinoma, Stage III Extrahepatic Bile Duct Cancer Trial in Scottsdale,

Withdrawn

Non-Resectable Cholangiocarcinoma
+12 more

Cisplatin
+4 more

Scottsdale, Arizona
+2 more

May 25, 2017

Bile Duct Adenocarcinoma, Stage III Intrahepatic Cholangiocarcinoma, Stage IVA Intrahepatic Cholangiocarcinoma Trial in Duarte

Withdrawn

Bile Duct Adenocarcinoma
+3 more

Capecitabine
+2 more

Duarte, California

City of Hope Medical Center

Apr 12, 2017